CD44 and lung carcinoma: In this proof-of-concept study, CD44 and EGFR receptors overexpressed in SK-LU-1 lung cancer cells were explored for dual-targeted delivery of wild-type (wt-) p53 and microRNA-125b (miR-125b) expressing plasmid DNA via HA-PEI/HA-PEG.